Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaming Hang

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Pageof 4